Loading company…
Twinpig Biolab develops tumor microenvironment therapies and drug delivery systems for oncology.
Twinpig Biolab develops oncology therapies targeting tumor microenvironments and nanoparticle delivery systems for agents such as mRNA, siRNA, peptides, and small molecules. Founded in 2019, the company is based in Seoul, South Korea, and raised KRW 1.5 billion in November 2025 from Scale Up Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in